Datasheet
12 Aug 2026
pMDI valves
PDF 1.7 MB
The Bespak BK357 is trusted by branded pharmaceutical companies to deliver their innovations, and by generic companies for reliable product approvals. Our range has now been expanded to ensure compatibility with suspension and solution formulations using both traditional HFA propellants, and lower Global Warming Potential (GWP) propellants HFA-152a and HFO-1234ze.
Content provided by our supplier
Bespak Europe Ltd.
-
Country/Region:United Kingdom
-
Founded:2024
-
On CPHI since:2016
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
Other Content from Bespak Europe Ltd. (2)
-
News Bespak achieves sustainability milestone with first life cycle assessment for pressurised Metered Dose Inhaler valve
This important step comes as a result of Bespak’s commitment to looking beyond low Global Warming Potential (GWP) propellants for opportunities to reduce carbon footprint in the pharma industry. -
News Chiesi and Bespak partner to advance Carbon Minimal Inhaler production with UK manufacturing site
Bespak’s leadership in low GWP propellant inhaler manufacturing along with significant expansion at its Holmes Chapel site strengthens Chiesi’s global supply chain resilience
Partnership aligns with the science-based climate commitments of both companies